{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:25:55Z","timestamp":1778736355079,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFB3506904"],"award-info":[{"award-number":["2023YFB3506904"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFB3506900"],"award-info":[{"award-number":["2023YFB3506900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","brachyjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.brachy.2024.12.004","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T12:27:01Z","timestamp":1741177621000},"page":"431-438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intraluminal brachytherapy using 125I seed strand combined with PTBD and Hepatic arterial infusion chemotherapy for unresectable Bismuth-Corlette III and IV stage hilar cholangiocarcinoma"],"prefix":"10.1016","volume":"24","author":[{"given":"Zi-Han","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7928-0310","authenticated-orcid":false,"given":"Fei-Hang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-You","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2024.12.004_bib0001","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s12094-015-1436-2","article-title":"Biliary tract cancers: SEOM clinical guidelines","volume":"17","author":"Benavides","year":"2015","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.brachy.2024.12.004_bib0002","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma-evolving concepts and therapeutic strategies","volume":"15","author":"Rizvi","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.brachy.2024.12.004_bib0003","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2024.12.004_bib0004","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00384-014-2063-z","article-title":"Hilar cholangiocarcinoma: Controversies on the extent of surgical resection aiming at cure","volume":"30","author":"Xiang","year":"2015","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.brachy.2024.12.004_bib0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.critrevonc.2016.11.012","article-title":"Cholangiocarcinoma","volume":"116","author":"Squadroni","year":"2017","journal-title":"Crit Rev Oncol Hemato"},{"key":"10.1016\/j.brachy.2024.12.004_bib0006","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/ajco.12592","article-title":"Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer","volume":"13","author":"Park","year":"2017","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.brachy.2024.12.004_bib0007","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.3390\/cancers15082384","article-title":"Locoregional therapy for intrahepatic cholangiocarcinoma","volume":"8","author":"Owen","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.brachy.2024.12.004_bib0008","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00270-011-0249-0","article-title":"Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinam","volume":"3","author":"Schnapauff","year":"2012","journal-title":"Cardiovasc Intervent Radio"},{"key":"10.1016\/j.brachy.2024.12.004_bib0009","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejso.2017.04.001","article-title":"Preoperative biliary drainage in hilar cholangiocarcinoma: Systematic review and meta-analysis","volume":"43","author":"Celotti","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.brachy.2024.12.004_bib0010","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1748-717X-8-292","article-title":"Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma","volume":"8","author":"Kim","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2024.12.004_bib0011","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jvir.2010.11.029","article-title":"Endovascular placement of iodine-125 seed strand and stent combined with chemoembolization for treatment of hepatocellular carcinoma with tumor thrombus in main portal vein","volume":"22","author":"Luo","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.brachy.2024.12.004_bib0012","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.brachy.2016.05.004","article-title":"A pilot study of intraluminal brachytherapy using 125I seed strand for locally advanced pancreatic ductal adenocarcinoma with obstructive jaundice","volume":"15","author":"Yang","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.12.004_bib0013","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4251\/wjgo.v5.i7.115","article-title":"Radiological diagnosis and staging of hilar cholangiocarcinoma","volume":"15","author":"Valls","year":"2013","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.brachy.2024.12.004_bib0014","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.critrevonc.2016.11.012","article-title":"Cholangiocarcinoma","volume":"116","author":"Squadroni","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.brachy.2024.12.004_bib0015","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4251\/wjgo.v8.i6.498","article-title":"Malignant biliary obstruction: From palliation to treatment","volume":"8","author":"Boulay","year":"2016","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.brachy.2024.12.004_bib0016","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.3748\/wjg.15.2908","article-title":"Ampullary carcinoma: Effect of preoperative biliarty drainage on surgical outcome","volume":"15","author":"Abdullah","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.brachy.2024.12.004_bib0017","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1155\/2015\/743417","article-title":"Partially covered self-expandable metal stents versus polyethylene stents for malignant biliary obstruction: A cost-effectiveness analysis","volume":"29","author":"Barkun","year":"2015","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.brachy.2024.12.004_bib0018","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-0031-1291633","article-title":"Biliary stenting: indications, choice of stent and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline","volume":"44","author":"Dumonceau","year":"2012","journal-title":"Endoscopy"},{"issue":"Suppl 1","key":"10.1016\/j.brachy.2024.12.004_bib0019","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.5009\/gnl.2010.4.S1.S82","article-title":"Multinodal oncological therapy comprising stents, brachytherapy, and regional chemotherapy for cholangiocarcinoma","volume":"Suppl 1","author":"Andra\u0161ina","year":"2010","journal-title":"Gut Liver"},{"key":"10.1016\/j.brachy.2024.12.004_bib0020","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.brachy.2018.03.002","article-title":"Iodine-125 seed brachytherapy inhibits non-small cell lung cancer by suppressing epithelial-mesenchymal transition","volume":"17","author":"He","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.12.004_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1533033819825845","article-title":"Permanent Iodine-125 Seed implantation for the treatment of nonresectable retroperitoneal malignant tumors","volume":"18","author":"Li","year":"2019","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.brachy.2024.12.004_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2021.101618","article-title":"Iodine-125 radioactive seed brachytherapy as a treatment for spine and bone metastases: A systematic review and meta-analysis","volume":"38","author":"Sharma","year":"2021","journal-title":"Surg Oncol"},{"key":"10.1016\/j.brachy.2024.12.004_bib0023","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s11604-021-01212-7","article-title":"Hepatic arterial infusion chemotherapy following simultaneous metallic stent placement and iodine-125 seed strands for advanced cholangiocarcinoma causing malignant obstructive jaundice: A propensity score matching study","volume":"40","author":"Wu","year":"2022","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.brachy.2024.12.004_bib0024","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10620-017-4899-x","article-title":"Efficacy of 125I versus Non-125I combined with transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma with obstructive jaundice","volume":"63","author":"Li","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.brachy.2024.12.004_bib0025","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1200\/JCO.2014.60.2219","article-title":"SWOG S0809: A Phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma","volume":"33","author":"Ben-Josef","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2024.12.004_bib0026","first-page":"102","article-title":"External beam radiation therapy with or without concurrent chemotherapy for patients with unresectable locally advanced hilar cholangiocarcinoma","volume":"62","author":"Chen","year":"2015","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.brachy.2024.12.004_bib0027","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.12.004_bib0028","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.2147\/OTT.S137491","article-title":"Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer","volume":"10","author":"Du","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.brachy.2024.12.004_bib0029","first-page":"417","article-title":"Enhanced activated T cell subsets in prostate cancer patients receiving iodine-125 low-dose-rate prostate brachytherapy","volume":"39","author":"Kubo","year":"2018","journal-title":"Oncol Rep"},{"key":"10.1016\/j.brachy.2024.12.004_bib0030","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.3748\/wjg.v18.i19.2364","article-title":"Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinma","volume":"19","author":"Isayama","year":"2012","journal-title":"World J Gastroenterol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T23:53:12Z","timestamp":1745279592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472125000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1538472125000029"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2024.12.004","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraluminal brachytherapy using 125I seed strand combined with PTBD and Hepatic arterial infusion chemotherapy for unresectable Bismuth-Corlette III and IV stage hilar cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2024.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}